{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:58:48Z","timestamp":1790456328530,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T00:00:00Z","timestamp":1100044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T00:00:00Z","timestamp":1100044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Anti-Sm antibodies, identified in 1966 by Tan and Kunkel, are highly specific serological markers for systemic lupus erythrematosus (SLE). Anti-Sm reactivity is found in 5\u201330% of SLE patients, depending on the autoantibody detection system and the racial background of the SLE population. The Sm autoantigen complex comprises at least nine different polypeptides. All of these core proteins can serve as targets of the anti-Sm B-cell response, but most frequently the B and D polypeptides are involved. Because the BB'Sm proteins share cross-reactive epitopes (PPPGMRPP) with U1 specific ribonucleoproteins, which are more frequently targeted by antibodies that are present in patients with mixed connective tissue disease, the SmD polypeptides are regarded as the Sm autoantigens that are most specific to SLE. It was recently shown that the polypeptides D1, D3 and BB' contain symmetrical dimethylarginine, which is a component of a major autoepitope within the carboxyl-terminus of SmD1. In one of those studies, a synthetic dimethylated peptide of SmD1 (amino acids 95\u2013119) exhibited significantly increased immunoreactivity as compared with unmodified SmD1 peptide. Using immobilized peptides, we confirmed that the dimethylated arginine residues play an essential role in the formation of major SmD1 and SmD3 autoepitopes. Moreover, we demonstrated that one particular peptide of SmD3 represents a more sensitive and more reliable substrate for the detection of a subclass of anti-Sm antibodies. Twenty-eight out of 176 (15.9%) SLE patients but only one out of 449 (0.2%) control individuals tested positive for the anti-SmD3 peptide (SMP) antibodies in a new ELISA system. These data indicate that anti-SMP antibodies are exclusively present in sera from SLE patients. Thus, anti-SMP detection using ELISA represents a new serological marker with which to diagnose and discriminate between systemic autoimmune disorders.<\/jats:p>","DOI":"10.1186\/ar1455","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T07:29:58Z","timestamp":1100158198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies"],"prefix":"10.1186","volume":"7","author":[{"given":"Michael","family":"Mahler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin J","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bl\u00fcthner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,11,10]]},"reference":[{"key":"1337_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0049-0172(95)80004-2","volume":"24","author":"CA von Muhlen","year":"1995","unstructured":"von Muhlen CA, Tan EM: Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum. 1995, 24: 323-358. 10.1016\/S0049-0172(95)80004-2.","journal-title":"Semin Arthritis Rheum"},{"key":"1337_CR2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.96.3.464","volume":"96","author":"EM Tan","year":"1966","unstructured":"Tan EM, Kunkel HG: Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol. 1966, 96: 464-471.","journal-title":"J Immunol"},{"key":"1337_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 1271-1277.","journal-title":"Arthritis Rheum"},{"key":"1337_CR4","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003, 349: 1526-1533. 10.1056\/NEJMoa021933.","journal-title":"N Engl J Med"},{"key":"1337_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-2362.1990.tb01870.x","volume":"20","author":"N Abuaf","year":"1990","unstructured":"Abuaf N, Johanet C, Chretien P, Absalon BI, Homberg JC, Buri JF: Detection of autoantibodies to Sm antigen in systemic lupus erythematosus by immunodiffusion, ELISA and immunoblotting: variability of incidence related to assays and ethnic origin of patients. Eur J Clin Invest. 1990, 20: 354-359.","journal-title":"Eur J Clin Invest"},{"key":"1337_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1006\/jaut.2001.0545","volume":"17","author":"HP Jaekel","year":"2001","unstructured":"Jaekel HP, Klopsch T, Benkenstein B, Grobe N, Baldauf A, Schoessler W, Werle E: Reactivities to the Sm autoantigenic complex and the synthetic SmD1-aa83\u2013119 peptide in systemic lupus erythematosus and other autoimmune diseases. J Autoimmun. 2001, 17: 347-354. 10.1006\/jaut.2001.0545.","journal-title":"J Autoimmun"},{"key":"1337_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/283220a0","volume":"283","author":"MR Lerner","year":"1980","unstructured":"Lerner MR, Boyle JA, Mount SM, Wolin SL, Steitz JA: Are snRNPs involved in splicing?. Nature. 1980, 283: 220-224. 10.1038\/283220a0.","journal-title":"Nature"},{"key":"1337_CR8","first-page":"B2.4\/1","volume-title":"Manual of biological Markers of disease","author":"SO Hoch","year":"1994","unstructured":"Hoch SO: The Sm antigens. Manual of biological Markers of disease. Edited by: Maini RN, van Venrooji WJ. 1994, Dordrecht, The Netherlands: Kluwer Academic, B2.4\/1-29."},{"key":"1337_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/art.1780400412","volume":"40","author":"H Brahms","year":"1997","unstructured":"Brahms H, Raker VA, van Venrooij WJ, Luhrmann R: A major, novel systemic lupus erythematosus autoantibody class recognizes the E, F, and G Sm snRNP proteins as an E-F-G complex but not in their denatured states. Arthritis Rheum. 1997, 40: 672-682.","journal-title":"Arthritis Rheum"},{"key":"1337_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1006\/clin.1997.4355","volume":"83","author":"Y Ou","year":"1997","unstructured":"Ou Y, Sun D, Sharp GC, Hoch SO: Screening of SLE sera using purified recombinant Sm-D1 protein from a baculovirus expression system. Clin Immunol Immunopathol. 1997, 83: 310-317. 10.1006\/clin.1997.4355.","journal-title":"Clin Immunol Immunopathol"},{"key":"1337_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1006\/clim.1999.4745","volume":"92","author":"SO Hoch","year":"1999","unstructured":"Hoch SO, Eisenberg RA, Sharp GC: Diverse antibody recognition patterns of the multiple Sm-D antigen polypeptides. Clin Immunol. 1999, 92: 203-208. 10.1006\/clim.1999.4745.","journal-title":"Clin Immunol"},{"key":"1337_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1365-2249.1990.tb03327.x","volume":"81","author":"S Barakat","year":"1990","unstructured":"Barakat S, Briand JP, Weber JC, van Regenmortel MH, Muller S: Recognition of synthetic peptides of Sm-D autoantigen by lupus sera. Clin Exp Immunol. 1990, 81: 256-262.","journal-title":"Clin Exp Immunol"},{"key":"1337_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0090-1229(92)90163-I","volume":"65","author":"LA Rokeach","year":"1992","unstructured":"Rokeach LA, Jannatipour M, Haselby JA, Hoch SO: Mapping of the immunoreactive domains of a small nuclear ribonucleoprotein-associated Sm-D autoantigen. Clin Immunol Immunopathol. 1992, 65: 315-324. 10.1016\/0090-1229(92)90163-I.","journal-title":"Clin Immunol Immunopathol"},{"key":"1337_CR14","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.4049\/jimmunol.150.8.3592","volume":"150","author":"M Hirakata","year":"1993","unstructured":"Hirakata M, Craft J, Hardin JA: Autoantigenic epitopes of the B and D polypeptides of the U1 snRNP. Analysis of domains recognized by the Y12 monoclonal anti-Sm antibody and by patient sera. J Immunol. 1993, 150: 3592-3601.","journal-title":"J Immunol"},{"key":"1337_CR15","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/eji.1830230525","volume":"23","author":"A Sabbatini","year":"1993","unstructured":"Sabbatini A, Bombardieri S, Migliorini P: Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein\u2013Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol. 1993, 23: 1146-1152.","journal-title":"Eur J Immunol"},{"key":"1337_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0090-1229(92)90104-V","volume":"62","author":"F De Keyser","year":"1992","unstructured":"De Keyser F, Hoch SO, Takei M, Dang H, De Keyser H, Rokeach LA, Talal N: Cross-reactivity of the B\/B' subunit of the Sm ribonucleoprotein autoantigen with proline-rich polypeptides. Clin Immunol Immunopathol. 1992, 62: 285-290. 10.1016\/0090-1229(92)90104-V.","journal-title":"Clin Immunol Immunopathol"},{"key":"1337_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1046\/j.1365-3083.1999.00640.x","volume":"50","author":"MR Arbuckle","year":"1999","unstructured":"Arbuckle MR, Reichlin M, Harley JB, James JA: Shared early autoantibody recognition events in the development of anti-Sm B\/B' in human lupus. Scand J Immunol. 1999, 50: 447-455. 10.1046\/j.1365-3083.1999.00640.x.","journal-title":"Scand J Immunol"},{"key":"1337_CR18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/1529-0131(200102)44:2<368::AID-ANR55>3.0.CO;2-6","volume":"44","author":"EL Greidinger","year":"2001","unstructured":"Greidinger EL, Hoffman RW: The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B'\/B proteins as predominant U1 RNP immunogens. Arthritis Rheum. 2001, 44: 368-375. 10.1002\/1529-0131(200102)44:2<368::AID-ANR55>3.3.CO;2-Y.","journal-title":"Arthritis Rheum"},{"key":"1337_CR19","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.4049\/jimmunol.168.4.2054","volume":"168","author":"MT McClain","year":"2002","unstructured":"McClain MT, Ramsland PA, Kaufman KM, James JA: Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens. J Immunol. 2002, 168: 2054-2062.","journal-title":"J Immunol"},{"key":"1337_CR20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1172\/JCI2749","volume":"102","author":"G Riemekasten","year":"1998","unstructured":"Riemekasten G, Marell J, Trebeljahr G, Klein R, Hausdorf G, Haupl T, Schneider-Mergener J, Burmester GR, Hiepe F: A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus. J Clin Invest. 1998, 102: 754-763.","journal-title":"J Clin Invest"},{"key":"1337_CR21","doi-asserted-by":"publisher","first-page":"17122","DOI":"10.1074\/jbc.M000300200","volume":"275","author":"H Brahms","year":"2000","unstructured":"Brahms H, Raymackers J, Union A, de Keyser F, Meheus L, L\u00fchrmann R: The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form amajor B-cell epitope for anti-Sm autoantibodies. J Biol Chem. 2000, 275: 17122-17129. 10.1074\/jbc.M000300200.","journal-title":"J Biol Chem"},{"key":"1337_CR22","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1017\/S135583820101442X","volume":"7","author":"H Brahms","year":"2001","unstructured":"Brahms H, Meheus L, de Brabandere V, Fischer U, Luhrmann R: Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B\/B' and the Sm-like protein LSm4, and their interaction with the SMN protein. RNA. 2001, 7: 1531-1542. 10.1017\/S135583820101442X.","journal-title":"RNA"},{"key":"1337_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324.","journal-title":"Arthritis Rheum"},{"key":"1337_CR24","first-page":"668","volume":"22","author":"K Tanimoto","year":"1995","unstructured":"Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H, Sato T, Kiuchi T, Ohashi Y: Classification criteria for polymyositis and dermatomyositis. J Rheumatol. 1995, 22: 668-674.","journal-title":"J Rheumatol"},{"key":"1337_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","volume":"52","author":"GC Sharp","year":"1972","unstructured":"Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR: Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972, 52: 148-159. 10.1016\/0002-9343(72)90064-2.","journal-title":"Am J Med"},{"key":"1337_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/art.1780360309","volume":"36","author":"C Vitali","year":"1993","unstructured":"Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S, et al: Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993, 36: 340-347.","journal-title":"Arthritis Rheum"},{"key":"1337_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Anonymous","year":"1980","unstructured":"Anonymous: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980, 23: 581-590.","journal-title":"Arthritis Rheum"},{"key":"1337_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/art.1780400304","volume":"40","author":"JS Smolen","year":"1997","unstructured":"Smolen JS, Butcher B, Fritzler MJ, Gordon T, Hardin J, Kalden JR, Lahita R, Maini RN, Reeves W, Reichlin M, et al: Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blotting. Arthritis Rheum. 1997, 40: 413-418.","journal-title":"Arthritis Rheum"},{"key":"1337_CR29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1128\/CDLI.7.3.436-443.2000","volume":"7","author":"K James","year":"2000","unstructured":"James K, Carpenter AB, Cook L, Marchand R, Nakamura RM: Development of the antinuclear and anticytoplasmic antibody consensus panel by the Association of Medical Laboratory Immunologists. Clin Diagn Lab Immunol. 2000, 7: 436-443. 10.1128\/CDLI.7.3.436-443.2000.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1337_CR30","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s001090100258","volume":"79","author":"M Mahler","year":"2001","unstructured":"Mahler M, Mierau R, Schlumberger W, Bluthner M: A population of autoantibodies against a centromere-associated protein A major epitope motif cross-reacts with related cryptic epitopes on other nuclear autoantigens and on the Epstein\u2013Barr nuclear antigen 1. J Mol Med. 2001, 79: 722-731. 10.1007\/s001090100258.","journal-title":"J Mol Med"},{"key":"1337_CR31","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/art.10330","volume":"46","author":"M Mahler","year":"2002","unstructured":"Mahler M, Mierau R, Genth E, Bluthner M: Development of a CENP-A\/CENP-B-specific immune response in a patient with systemic sclerosis. Arthritis Rheum. 2002, 46: 1866-1872. 10.1002\/art.10330.","journal-title":"Arthritis Rheum"},{"key":"1337_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1521-6616(03)00037-8","volume":"107","author":"M Mahler","year":"2003","unstructured":"Mahler M, Bluthner M, Pollard KM: Advances in B-cell epitope analysis of autoantigens in connective tissue diseases. Clin Immunol. 2003, 107: 65-79. 10.1016\/S1521-6616(03)00037-8.","journal-title":"Clin Immunol"},{"key":"1337_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-662-09229-3_4","volume-title":"Peptide Arrays on Membrane Supports, Synthesis and Applications","author":"H Gausepohl","year":"2002","unstructured":"Gausepohl H, Behn C: Automated synthesis of solid-phase bound peptides. Peptide Arrays on Membrane Supports, Synthesis and Applications. Edited by: Koch J, Mahler M. 2002, Heidelberg, New York: Springer Verlag, 55-68."},{"key":"1337_CR34","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1074\/mcp.M300088-MCP200","volume":"2","author":"FM Boisvert","year":"2003","unstructured":"Boisvert FM, Cote J, Boulanger MC, Richard S: A proteomic analysis of arginine-methylated protein complexes. Mol Cell Proteomics. 2003, 2: 1319-1330. 10.1074\/mcp.M300088-MCP200.","journal-title":"Mol Cell Proteomics"},{"key":"1337_CR35","first-page":"1679","volume":"20","author":"A Sabbatini","year":"1993","unstructured":"Sabbatini A, Dolcher MP, Marchini B, Bombardieri S, Migliorini P: Mapping of epitopes on the SmD molecule: the use of multiple antigen peptides to measure autoantibodies in systemic lupus erythematosus. J Rheumatol. 1993, 20: 1679-1683.","journal-title":"J Rheumatol"},{"key":"1337_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/jaut.1994.1014","volume":"7","author":"B Marchini","year":"1994","unstructured":"Marchini B, Dolcher MP, Sabbatini A, Klein G, Migliorini P: Immune response to different sequences of the EBNA I molecule in Epstein\u2013Barr virus-related disorders and in autoimmune diseases. J Autoimmun. 1994, 7: 179-191. 10.1006\/jaut.1994.1014.","journal-title":"J Autoimmun"},{"key":"1337_CR37","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1172\/JCI119856","volume":"100","author":"JA James","year":"1997","unstructured":"James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB: An increased prevalence of Epstein\u2013Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest. 1997, 100: 3019-3026.","journal-title":"J Clin Invest"},{"key":"1337_CR38","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.4049\/jimmunol.172.2.1287","volume":"172","author":"I Kang","year":"2004","unstructured":"Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, Pamer EG, Howe JG, Craft J: Defective control of latent Epstein\u2013Barr virus infection in systemic lupus erythematosus. J Immunol. 2004, 172: 1287-1294.","journal-title":"J Immunol"},{"key":"1337_CR39","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.4049\/jimmunol.150.4.1579","volume":"150","author":"DD Bloom","year":"1993","unstructured":"Bloom DD, Davignon JL, Cohen PL, Eisenberg RA, Clarke SH: Overlap of the anti-Sm and anti-DNA responses of MRL\/Mp-lpr\/lpr mice. J Immunol. 1993, 150: 1579-1590.","journal-title":"J Immunol"},{"key":"1337_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1172\/JCI116980","volume":"93","author":"M Reichlin","year":"1994","unstructured":"Reichlin M, Martin A, Taylor-Albert E, Tsuzaka K, Zhang W, Reichlin MW, Koren E, Ebling FM, Tsao B, Hahn BH: Lupus autoantibodies to native DNA cross-react with the A and D SnRNP polypeptides. J Clin Invest. 1994, 93: 443-449.","journal-title":"J Clin Invest"},{"key":"1337_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/clin.1995.1010","volume":"74","author":"W Zhang","year":"1995","unstructured":"Zhang W, Reichlin M: IgM anti-A and D SnRNP proteins and IgM anti-dsDNA are closely associated in SLE sera. Clin Immunol Immunopathol. 1995, 74: 70-76. 10.1006\/clin.1995.1010.","journal-title":"Clin Immunol Immunopathol"},{"key":"1337_CR42","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1083\/jcb.200207028","volume":"159","author":"FM Boisvert","year":"2002","unstructured":"Boisvert FM, Cote J, Boulanger MC, Cleroux P, Bachand F, Autexier C, Richard S: Symmetrical dimethylarginine methylation is required for the localization of SMN in Cajal bodies and pre-mRNA splicing. J Cell Biol. 2002, 159: 957-969. 10.1083\/jcb.200207028.","journal-title":"J Cell Biol"},{"key":"1337_CR43","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1002\/1529-0131(200110)44:10<2435::AID-ART408>3.0.CO;2-0","volume":"44","author":"G Riemekasten","year":"2001","unstructured":"Riemekasten G, Kawald A, Weiss C, Meine A, Marell J, Klein R, Hocher B, Meisel C, Hausdorf G, Manz R, et al: Strong acceleration of murine lupus by injection of the SmD1(83\u2013119) peptide. Arthritis Rheum. 2001, 44: 2435-2445. 10.1002\/1529-0131(200110)44:10<2435::AID-ART408>3.0.CO;2-0.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Res Ther"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar1455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar1455\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar1455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:24:55Z","timestamp":1728383095000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar1455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,10]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,11]]}},"alternative-id":["1337"],"URL":"https:\/\/doi.org\/10.1186\/ar1455","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,10]]},"assertion":[{"value":"9 August 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2004","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2004","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2004","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R19"}}